Type 2 diabetes remission is defined as achieving specified glycated hemoglobin (A1C)
thresholds without any antihyperglycemic medications for a minimum of 3 months: remission
to prediabetes (A1C between 6.0% and 6.4%) and remission to normal glucose concentrations
(A1C <6.0%).
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of DiabetesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Novel agents for the treatment of type 2 diabetes.Diabetes spectrum: A publication of the American Diabetes Association. 2014; 27: 100-112
- Fighting for a hand to hold: Confronting medical colonialism against Indigenous children in Canada.McGill-Queen’s University Press, Quebec2020
- Truth and Reconciliation Commission of Canada: Calls to Action: Truth and Reconciliation.Commission of Canada, 2015
- Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada: Methods.Can J Diabetes. 2018; 42: S6-S9
- Remission of type 2 diabetes: User’s guide.Can J Diabetes. 2022; 46: 762-774
- Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada: Weight Management in Diabetes.Can J Diabetes. 2018; 42: S124-S129
- Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada: Cardiovascular Protection in People With Diabetes.Can J Diabetes. 2018; 42: S162-S169
- Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada: Nutrition Therapy.Can J Diabetes. 2018; 42: S64-S79
- Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada: Physical Activity and Diabetes.Can J Diabetes. 2018; 42: S54-S63
- Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada: Reducing the Risk of Developing Diabetes.Can J Diabetes. 2018; 42: S20-S26
- Pharmacologic glycemic management of type 2 diabetes in adults: 2020 update.Canadian Journal of Diabetes. 2020; 44: 575-591
- Consensus report: Definition and interpretation of remission in type 2 diabetes.Diabetic medicine: A journal of the British Diabetic Association. 2022; 39e14669
- Consensus report: Definition and interpretation of remission in type 2 diabetes.The Journal of Clinical Endocrinology and Metabolism. 2022; 107: 1-9
- Consensus Report: Definition and interpretation of remission in type 2 diabetes.Diabetes Care. 2021;
- Consensus report: Definition and interpretation of remission in type 2 diabetes.Diabetologia. 2021; 64: 2359-2366
- Diabetes Australia Position Statement on Type 2 Diabetes Remission.(October 2021. Accessed October 5, 2022.)
- Defining remission of type 2 diabetes in research studies: A systematic scoping review.PLoS Med. 2020; 17e1003396
- Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada: Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome.Can J Diabetes. 2018; 42: S10-S15
- Diabetes Canada Clinical Practice Guidelines: Processes Manual 2021.([Available from:) (])
- Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: A systematic review and meta-analysis.Obes Surg. 2014; 24: 437-455
- 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes—2022.Diabetes Care. 2021; 45: S113-S124
- Late relapse of diabetes after bariatric surgery: Not rare, but not a failure.Diabetes Care. 2020; 43: 534-540
- IFSO-APC consensus statements 2011.Obes Surg. 2012; 22: 677-684
- Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss, Comorbidities, and Reflux at 10 Years in Adult Patients With Obesity: The SLEEVEPASS Randomized Clinical Trial.JAMA Surg. 2022;
- Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy for Remission of Type 2 Diabetes.The Journal of clinical endocrinology and metabolism. 2021; 106: 922-933
- Comparison of the effect of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.Obesity Reviews. 2020; 21e13011
- Remission of Type 2 Diabetes and Sleeve Gastrectomy in Morbid Obesity: a Comparative Systematic Review and Meta-analysis.Obes Surg. 2019; 29: 4066-4076
- Surgical outcome of laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass for resolution of type 2 diabetes mellitus: A systematic review and meta-analysis.World journal of gastroenterology : WJG. 2020; 26: 865-876
- Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis.Annals of surgery. 2015; 261: 421-429
- Laparoscopic Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy for Type 2 Diabetes Mellitus in Nonseverely Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Obes Surg. 2020; 30: 1660-1670
- Roux-En-Y Gastric Bypass in Type 2 Diabetes Patients with Mild Obesity: a Systematic Review and Meta-analysis.Obes Surg. 2017; 27: 2733-2739
- Impact of roux-en Y gastric bypass surgery on prognostic factors of type 2 diabetes mellitus: meta-analysis and systematic review.Diabetes/metabolism research and reviews. 2015; 31: 653-662
- Diabetes Remission and Relapse After Bariatric Surgery: a Nationwide Population-Based Study.Obes Surg. 2020; 30: 4810-4820
- Relapse of Diabetes After Roux-en-Y Gastric Bypass for Patients With Obesity: 12 Years Follow-up Study.Obes Surg. 2020; 30: 4834-4839
- Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial.Lancet Diabetes Endocrinol. 2019; 7: 344-355
- Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.Lancet. 2018; 391: 541-545
- Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial.Lancet Diabetes Endocrinol. 2020; 8: 477-489
- Type 2 diabetes remission 1 year after an intensive lifestyle intervention: A secondary analysis of a randomized clinical trial.Diabetes Obes Metab. 2019; 21: 2257-2266
- Association of an Intensive Lifestyle Intervention With Remission of Type 2 Diabetes.Jama. 2012; 308: 2489-2496
- Better reporting of interventions: Template for intervention description and replication (TIDieR) checklist and guide.BMJ. 2014; 348: g1687https://doi.org/10.1136/bmj.g1687
- The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial.BMC Fam Pract. 2016; 17: 20
- Understanding the mechanisms of reversal of type 2 diabetes.Lancet Diabetes Endocrinol. 2019; 7: 726-736
- Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort.Diabetologia. 2018; 61: 589-598
- Calorie restriction and reversal of type 2 diabetes.Expert review of endocrinology & metabolism. 2016; 11: 521-528
- Type 2 diabetes: Etiology and reversibility.Diabetes care. 2013; 36: 1047-1055
- Effect of an Intensive Lifestyle Intervention on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.JAMA. 2017 Aug 15; 318: 637-646
- Head-to-head comparison of intensive lifestyle intervention (U-TURN) versus conventional multifactorial care in patients with type 2 diabetes: protocol and rationale for an assessor-blinded, parallel group and randomised trial.BMJ Open. 2015 Dec 9; 5e009764
- Diabetes Canada Position Statement on Low-Carbohydrate Diets for Adults With Diabetes: A Rapid Review.Can J Diabetes. 2020; 44: 295-299
- Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical Trial.Front Endocrinol (Lausanne). 2019; 10: 348
- Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study.Diabetes Ther. 2018;
- Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data.Bmj. 2021; 372: m4743
- Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis.Lancet Diabetes Endocrinol. 2013; 1: 28-34
- Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.Lancet. 2008; 371: 1753-1760
- Remission of Type 2 Diabetes Following a Short-term Intervention With Insulin Glargine, Metformin, and Dapagliflozin.The Journal of Clinical Endocrinology & Metabolism. 2020; 105: 2532-2540
- Remission of Type 2 Diabetes Following a Short-term Intensive Intervention With Insulin Glargine, Sitagliptin, and Metformin: Results of an Open-label Randomized Parallel-Design Trial.Diabetes care. 2022; 45: 178-185
- Digital medicine's march on chronic disease.Nature biotechnology. 2016; 34: 239-246
- Physiological Outcomes of an Internet Disease Management Program vs. In-person Counselling:A Randomized, Controlled Trial.Can J Diabetes. 2006; 30 (Epub 2012 Dec 10): 397-405https://doi.org/10.1016/S1499-2671(06)04008-1
- Change in Glycemic Control With Use of a Digital Therapeutic in Adults With Type 2 Diabetes: Cohort Study.JMIR Diabetes. 2018; 3: e4
- How do we define cure of diabetes?.Diabetes care. 2009; 32: 2133-2135
- Assessing the Clinical Robustness of Digital Health Startups: Cross-sectional Observational Analysis.J Med Internet Res. 2022; 24e37677
- Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis.BMJ open. 2017; 7e015949
- Glycated Hemoglobin and All-Cause and Cause-Specific Mortality Among Adults With and Without Diabetes.The Journal of Clinical Endocrinology & Metabolism. 2019; 104: 3345-3354
- Comparative effectiveness of bariatric surgeries in patients with obesity and type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials.Obesity Reviews. 2020; 21e13030
- Long-term outcomes of Roux-en-Y gastric bypass versus medical therapy for patients with type 2 diabetes: a meta-analysis of randomized controlled trials.Surg Obes Relat Dis. 2021 Jul; 17 (Epub 2021 Mar 9. PMID: 33863632): 1334-1343https://doi.org/10.1016/j.soard.2021.03.001
- Metabolic surgery for the treatment of type 2 diabetes: A network meta-analysis of randomized controlled trials.Diabetes Obes Metab. 2020 Aug; 22 (Epub 2020 May 4. PMID: 32243058): 1378-1387https://doi.org/10.1111/dom.14045
- Outcomes of Bariatric Surgery Versus Medical Management for Type 2 Diabetes Mellitus: a Meta-Analysis of Randomized Controlled Trials.Obes Surg. 2019 Mar; 29 (PMID:30402804): 964-974https://doi.org/10.1007/s11695-018-3552-x
Article info
Publication history
Published online: November 11, 2022
Identification
Copyright
Crown Copyright © 2022 Published on behalf of Canadian Diabetes Association.
